Key Research Features Triple-hormone receptor agonist GIP + GLP-1 + Glucagon (GCGR) Tuned potency hierarchy across all three receptor targets C20 fatty diacid moiety albumin binding, ~6-day half-life in research models Simultaneous energy intake and energy expenditure pathway modeling 99% HPLC-verified purity LC-MS sequence and molecular weight identity confirmed Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, Retatrutide should be: Stored at 20C in a tightly sealed container Protected from light and moisture Reconstituted in sterile or bacteriostatic water Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information Currently an Investigational New Drug (IND) under active Phase 3 clinical investigation (TRIUMPH and TRANSCEND trial series) Not FDA-approved for any therapeutic indication as of current date Prohibited by the World Anti-Doping Agency (WADA) under S2 Peptide Hormones, Growth Factors, Related Substances, and Mimetics Supplied strictly as a Research Use Only (RUO) material Why Choose Summit Pep Labs
However, analysts can estimate pricing based on similar medications like tirzepatide and semaglutide
A 'loophole' allowing imitation drugs to be mass-produced Compounding pharmacies are licensed to create medicine themselves, and can manufacture custom pharmaceuticals for patients with a prescription who cannot find a commercially made, mass-produced option
Lake at UTHealth Houston
The news is overwhelmingly positive
Based on current programs, eligibility typically requires: Household income below 300% of federal poverty level (approximately $47,880 for individuals, $99,000 for families of four)
.png)
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
